Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 63.38B | 65.44B | 63.61B | 64.88B | 58.79B | 45.21B |
Gross Profit | 6.21B | 5.96B | 7.17B | 6.39B | 4.37B | 4.33B |
EBITDA | 5.17B | 3.43B | 5.78B | 3.98B | 2.63B | 2.96B |
Net Income | 1.41B | 624.90M | 2.70B | 1.51B | 702.95M | 1.39B |
Balance Sheet | ||||||
Total Assets | 48.10B | 46.05B | 48.01B | 46.36B | 42.75B | 34.73B |
Cash, Cash Equivalents and Short-Term Investments | 3.60B | 4.39B | 3.19B | 2.84B | 1.96B | 2.19B |
Total Debt | 14.11B | 13.50B | 15.72B | 17.04B | 16.00B | 10.00B |
Total Liabilities | 23.00B | 21.47B | 23.69B | 25.25B | 23.48B | 16.79B |
Stockholders Equity | 25.05B | 24.54B | 24.29B | 21.09B | 19.26B | 17.92B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 3.91B | 1.34B | -63.61M | -6.29B | -1.40B |
Operating Cash Flow | 0.00 | 5.60B | 3.22B | 4.91B | -4.75B | 153.83M |
Investing Cash Flow | 0.00 | -1.46B | -1.96B | -4.98B | -1.36B | -1.49B |
Financing Cash Flow | 0.00 | -2.72B | -1.63B | 890.99M | 5.70B | 1.46B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
84 Outperform | ¥6.54B | 3.82 | 3.43% | 6.18% | 206.74% | ||
78 Outperform | ¥5.62B | 9.26 | 2.81% | 6.71% | 1.17% | ||
75 Outperform | ¥6.45B | 17.86 | ― | 14.66% | ― | ||
68 Neutral | ¥5.58B | 8.93 | 6.16% | 2.88% | -76.82% | ||
68 Neutral | ¥6.35B | 2.86 | 1.95% | 14.31% | -15.43% | ||
63 Neutral | $33.61B | 6.06 | -11.53% | 1.82% | 5.53% | -18.79% | |
48 Neutral | ¥4.70B | ― | 2.01% | -32.99% | -1496.54% |